Press Releases

RESEARCH TRIANGLE PARK, N.C. , June 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company will be

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--May 11, 2022-- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab , Executive Vice President and Chief Financial Officer, will participate in the H. C. Wainwright Global Investment Conference in Miami, Florida .

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--May 4, 2022-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Apr. 27, 2022-- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2022

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Feb. 28, 2022-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Feb. 22, 2022-- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jan. 10, 2022-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2021 year-end

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Dec. 29, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando , President and Chief Executive Officer, and Shameze Rampertab , Executive Vice President and Chief Financial Officer, will participate in the 40th

RZD Medicine is the second Russian hospital to initiate a Senhance Surgical System program RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Nov. 29, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to

Franklin Medical Center to become 4th Senhance Hospital in Louisiana RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Nov. 15, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of